US Bancorp DE Acquires 672 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

US Bancorp DE grew its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 20.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,978 shares of the company’s stock after purchasing an additional 672 shares during the period. US Bancorp DE’s holdings in Prestige Consumer Healthcare were worth $287,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. State Board of Administration of Florida Retirement System raised its holdings in Prestige Consumer Healthcare by 77.4% in the first quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after purchasing an additional 11,000 shares during the period. Lombard Odier Asset Management USA Corp acquired a new stake in Prestige Consumer Healthcare in the second quarter worth $550,000. CANADA LIFE ASSURANCE Co raised its holdings in Prestige Consumer Healthcare by 19.4% in the first quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock worth $3,453,000 after purchasing an additional 7,715 shares during the period. Sequoia Financial Advisors LLC raised its holdings in Prestige Consumer Healthcare by 12.9% in the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after purchasing an additional 1,120 shares during the period. Finally, Atria Investments Inc acquired a new stake in Prestige Consumer Healthcare in the first quarter worth $1,246,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PBH has been the topic of a number of research analyst reports. DA Davidson restated a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday. Jefferies Financial Group restated a “hold” rating and set a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Stock Up 0.8 %

Prestige Consumer Healthcare stock opened at $82.32 on Thursday. The company has a market cap of $4.07 billion, a P/E ratio of 20.08, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $83.13. The company has a fifty day simple moving average of $72.84 and a 200 day simple moving average of $70.00. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.09. The business had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.07 earnings per share. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.